Login / Signup

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia.

Yiyun WangYingying YangRuimin HongHouli ZhaoGuoqing WeiWenjun WuHuijun XuJiazhen CuiYanlei ZhangAlex H ChangYongxian HuHe Huang
Published in: Blood cancer journal (2020)
Keyphrases
  • cell therapy
  • acute lymphoblastic leukemia
  • stem cells
  • allogeneic hematopoietic stem cell transplantation
  • mesenchymal stem cells
  • cancer therapy
  • multiple myeloma
  • drug delivery
  • bone marrow